반응식
[C:1]([O:5][C:6](=[O:21])[CH2:7][C:8](=[O:20])[C:9]([C:12]1[CH:17]=[CH:16][CH:15]=[C:14]([O:18][CH3:19])[N:13]=1)([CH3:11])[CH3:10])([CH3:4])([CH3:3])[CH3:2].Cl[C:23]1[CH:30]=[CH:29][C:26]([C:27]#[N:28])=[CH:25][C:24]=1[N+]([O-])=O>>[C:1]([O:5][C:6]([C:7]1[C:23]2[CH:24]=[CH:25][C:26]([C:27]#[N:28])=[CH:29][C:30]=2[O:20][C:8]=1[C:9]([C:12]1[CH:17]=[CH:16][CH:15]=[C:14]([O:18][CH3:19])[N:13]=1)([CH3:11])[CH3:10])=[O:21])([CH3:2])([CH3:3])[CH3:4]참가 물질
3
실험 절차
According to the method that is used for the preparation of Compound FR1, the title compound was synthesized from 4-(6-methoxy-pyridin-2-yl)-4-methyl-3-oxo-pentanoic acid tert-butyl ester and 4-chloro-3-nitrobenzonitrile.
출처 및 근거
- ORD 기록
- ord-7e7ff614c63f474d92f2da8d138cf8ab
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09440922B2
연결된 노트
불러오는 중…